Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment.
Aline SchönenbergTino PrellPublished in: PloS one (2022)
The PDQ-39 can be used to measure QoL in cognitively impaired PD patients, thus test scores indicating cognitive impairment alone should not lead to exclusion of PD patients from clinical studies. Although the correlation between BDI-II and PDQ-39 shrinks for some subdomains in cognitively impairment patients, this finding may be explained by the difference in PD severity, as factors influencing QoL may shift with increasing age and PD symptoms.